Buckley, H. L., Collinson, F. J., Ainsworth, G., Poad, H., Flanagan, L., Katona, E., . . . Vasudev, N. S. (2019). PRISM protocol: A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma. BMC Cancer.
Stile di citazione ChicagoBuckley, Hannah L., et al. "PRISM Protocol: A Randomised Phase II Trial of Nivolumab in Combination With Alternatively Scheduled Ipilimumab in First-line Treatment of Patients With Advanced or Metastatic Renal Cell Carcinoma." BMC Cancer 2019.
Citazione MLABuckley, Hannah L., et al. "PRISM Protocol: A Randomised Phase II Trial of Nivolumab in Combination With Alternatively Scheduled Ipilimumab in First-line Treatment of Patients With Advanced or Metastatic Renal Cell Carcinoma." BMC Cancer 2019.